Reedijk, A. M. J., Zijtregtop, E. A. M., Coebergh, J. W. W., Meyer-Wentrup, F. A. G., Hebeda, K. M., Zwaan, C. M., Janssens, G. O. R., Pieters, R., Plattel, W. J., Dinmohamed, A. G., Zijlstra, J. M., Kremer, L. C. M., Lugtenburg, P. J., Beishuizen, A., & Karim-Kos, H. E. (2020). Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015. British Journal of Haematology, 189(6), 1093-1106. https://doi.org/10.1111/bjh.16491

Kahle, X. U., de Jesus, F. M. M., Glaudemans, A. W. J. M., Lub-de Hooge, M. N., Jorritsma-Smit, A., Plattel, W. J., van Meerten, T., Diepstra, A., van den Berg, A., Kwee, T. C., Noordzij, W., de Vries, E. G. E., & Nijland, M. (2020). Molecular imaging in lymphoma beyond F-18-FDG-PET: understanding the biology and its implications for diagnostics and therapy. Lancet Haematology, 7(6), E479-E489. https://doi.org/10.1016/S2352-3026(20)30065-X

Driessen, J., Visser, O., Zijlstra, J. M., Lugtenburg, P. J., Plattel, W. J., Kersten, M. J., & Dinmohamed, A. G. (2020). Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989-2017. Leukemia. https://doi.org/10.1038/s41375-020-0875-0

Nijland, M., Bakker, M., Meijer, K., & Plattel, W. (2020). Borrelia burgdorferi mimicking central nervous system relapse in diffuse large B cell lymphoma. Annals of Hematology, (12), 2947-2948. https://doi.org/10.1007/s00277-020-04022-5

Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D., & Hagenbeek, A. (2020). Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica. https://doi.org/10.3324/haematol.2019.243238

Tan, G. W., Terpstra, M. M., Kok, K., Diepstra, A., van den Berg, A., & Plattel, W. (2020). Cell-free DNA as biomarker in Hodgkin lymphoma patients. Klinische Pädiatrie, 232(2), 89-89. https://doi.org/10.1055/s-0040-1701844

Plattel, W. J., Visser, L., Diepstra, A., Glaudemans, A. W. J. M., Nijland, M., van Meerten, T., Kluin-Nelemans, H. C., van Imhoff, G. W., & van den Berg, A. (2020). Interim thymus and activation regulated chemokine versus interim F-18-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation. British Journal of Haematology, 190(1), 40-44. https://doi.org/10.1111/bjh.16514

Kahle, X. U., Montes de Jesus, F. M., Kwee, T. C., van Meerten, T., Diepstra, A., Rosati, S., Glaudemans, A. W. J. M., Noordzij, W., Plattel, W. J., & Nijland, M. (2019). Relationship between semiquantitative 18F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma. Scientific Reports, 9(1), [11073]. https://doi.org/10.1038/s41598-019-47453-5

Klaassen, S. H. C., Lemmink, H. H., Bijzet, J., Glaudemans, A. W. J. M., Bos, R., Plattel, W., van den Berg, M. P., Slart, R. H. J. A., Nienhuis, H. L. A., van Veldhuisen, D. J., & Hazenberg, B. P. C. (2017). Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G). Cardiovascular Pathology, 29, 19-22. https://doi.org/10.1016/j.carpath.2017.04.002

Plattel, W. J., Alsada, Z. N. D., van Imhoff, G. W., Diepstra, A., van den Berg, A., & Visser, L. (2016). Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC. British Journal of Haematology, 175(5), 868-875. https://doi.org/10.1111/bjh.14317

Plattel, W. J., Berg, van den, A., Visser, L., Glaudemans, A., Diepstra, A., & van Imhoff, G. (2016). Mid-treatment TARC and mid-treatment FGD-PET predict for progression free survival in classical hodgkin lymphom. Haematologica, 101, 31-31. [T014].

Liang, Z., Diepstra, A., Xu, C., van Imhoff, G., Plattel, W., Van Den Berg, A., & Visser, L. (2014). Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma. PLoS ONE, 9(1), [e87474]. https://doi.org/10.1371/journal.pone.0087474

Xu, C., Plattel, W., van den Berg, A., Ruether, N., Huang, X., Wang, M., de Jong, D., Vos, H., van Imhoff, G., Viardot, A., Moeller, P., Poppema, S., Diepstra, A., & Visser, L. (2012). Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma. Haematologica, 97(4), 572-578. https://doi.org/10.3324/haematol.2011.056101

Plattel, W. J., van den Berg, A., Visser, L., van der Graaf, A-M., Pruim, J., Vos, H., Hepkema, B., Diepstra, A., & van Imhoff, G. W. (2012). Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma. Haematologica, 97(3), 410-415. https://doi.org/10.3324/haematol.2011.053199

Plattel, W. J., Kluin-Nelemans, H. C., de Bock, G. H., & van Imhoff, G. W. (2011). Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma. Bone marrow transplantation, 46(6), 827-834. https://doi.org/10.1038/bmt.2010.188